Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock; Increases Common…
ST. PETERSBURG, Fla., Dec. 01, 2022 (GLOBE NEWSWIRE) -- On December 1, 2022, the Raymond James Financial, Inc. (NYSE: RJF) Board…
ROHM and BASiC Semiconductor Form a Strategic Partnership
Contributing to the technical innovation of new energy vehicles through the development of automotive SiC power devices ROHM and…
Alvotech Announces Changes to its Leadership Team
Hafrun Fridriksdottir, previously Executive VP and Head of Global R&D at Teva, will become Chief Operating Officer Mark…
Sun Communities, Inc. Announces Dates for Fourth Quarter 2022 Earnings Release and Conference Call
Southfield, MI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment…
Sun Communities, Inc. Declares Fourth Quarter 2022 Distribution
Southfield, MI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment…
Verisk CEO Lee Shavel to Assume Role as President, as Mark Anquillare Steps Down
JERSEY CITY, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics provider, announced…
MALACHITE INNOVATIONS ANNOUNCES EXPANSION OF SENIOR LEADERSHIP TEAM AND ENGAGEMENT OF TWO NEW…
CLEVELAND, OHIO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company…
Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and…
Affirms plans to report topline Phase 1 results in 2022 and to initiate Phase 2a influenza human challenge trial in 2023 BOTHELL,…
ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 1, 2022 – ObsEva SA (NASDAQ:…
IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical…
LAWRENCEVILLE, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug development company,…